{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:43:38Z","timestamp":1786653818367,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Introduction:<\/jats:title>\n \n Visceral Leishmaniasis (VL), caused by\n Leishmania donovani<\/jats:italic>\n , is a fatal disease, necessitating an effective vaccine. This study aims to develop a vaccine by evaluating the combination of recombinant kinesin protein (rKIN) with Bacille Calmette\u2013Guerin (BCG) as an adjuvant against experimental VL.\n <\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n The immune response was analyzed against the purified rKIN of\n L. donovani<\/jats:italic>\n with and without BCG adjuvant by using BALB\/C mice. Mice were divided into 6 groups comprising of 6 animals in each group for the vaccine intramuscularly. All 6 Groups were immunized either with BCG, rKIN, or combination of the two, with different doses. Saline was used as negative control. Each group was further divided into 2 subgroups. One subgroup of animals from each group was challenged with\n L. donovani<\/jats:italic>\n promastigotes 1 \u00d7 10\n 6<\/jats:sup>\n cells\/100 \u03bcl per animal. The extent of protection was evaluated by estimating the reduction in the number of parasites in the spleen, quantity of nitric oxide (NO), reactive oxygen species (ROS) in the peritoneal cells, and production of cytokines in blood serum.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Significant parasite reduction (70%\u201390%) was observed in the spleens of groups receiving rKIN (50\u00b5g or 100\u00b5g) with BCG. NO and ROS production increased by 60%\u201395% and 70%\u201390%, respectively. The 100\u00b5g rKIN with BCG group demonstrated substantial protection (\n P<\/jats:italic>\n < 0.001) with upregulated interferon-gamma (IFN-\u03b3), tumor necrosis factor, interleukin-2 (IL-2), and downregulated IL-4, IL-10, and IL-17. Statistical analysis confirmed significant differences (\n P<\/jats:italic>\n < 0.001) between vaccinated and control groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n The combination of 100\u00b5g rKIN with BCG shows potential as a vaccine candidate against VL.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/tp.tp_10_25","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:00:43Z","timestamp":1778007643000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant kinesin protein of Leishmania donovani and Bacille Calmette\u2013Guerin as an immunomodulatory agent: Insights into their role against visceral leishmaniasis"],"prefix":"10.4103","volume":"16","author":[{"given":"Saumya","family":"Srivastava","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi, India"},{"name":"Department of Microbiology, Central University of Punjab, Bhatinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarman","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi, India"},{"name":"Advanced Centre for Chronic and Rare Diseases, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"e0006659","DOI":"10.1371\/journal.pntd.0006659","article-title":"Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent","volume":"12","author":"Thakur","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3201\/eid1810.111083","article-title":"Visceral leishmaniasis in rural Bihar, India","volume":"18","author":"Hasker","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasit Vectors"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.1901362","article-title":"Development and characterization of an avirulent Leishmania major strain","volume":"204","author":"Jha","year":"2020","journal-title":"J Immunol"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: Analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalh\u00e3es","year":"2005","journal-title":"Scand J Immunol"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"624009","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.185.5.867","article-title":"Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model","volume":"185","author":"Murray","year":"1997","journal-title":"J Exp Med"},{"key":"R9-20260506","first-page":"54","article-title":"Immune responses in leishmaniasis: An overview","volume":"7","author":"Costa-da-Silva","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pep.2005.07.027","article-title":"Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani","volume":"46","author":"Sivakumar","year":"2006","journal-title":"Protein Expr Purif"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/CVI.00433-07","article-title":"Kinesin motor domain of Leishmania donovani as a future vaccine candidate","volume":"15","author":"Dey","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"e3030","DOI":"10.21769\/BioProtoc.3030","article-title":"Expression and Ni-NTA-agarose purification of recombinant hepatitis C Virus E2Ectodomain produced in a baculovirus expression system","volume":"8","author":"G\u00f3mez-Guti\u00e9rrez","year":"2018","journal-title":"Bio Protoc"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: Evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00436-012-2847-4","article-title":"Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis","volume":"111","author":"Datta","year":"2012","journal-title":"Parasitol Res"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"85154","DOI":"10.1155\/2007\/85154","article-title":"Immune response regulation by leishmania secreted and nonsecreted antigens","volume":"2007","author":"Santar\u00e9m","year":"2007","journal-title":"J Biomed Biotechnol"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/biomedicines9050516","article-title":"BCG cell wall skeleton as a vaccine adjuvant protects both infant and old-aged mice from influenza virus infection","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect Immun"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2012.00144","article-title":"Adjuvants for Leishmania vaccines: From models to clinical application","volume":"3","author":"Raman","year":"2012","journal-title":"Front Immunol"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.exppara.2006.04.006","article-title":"Leishmania major: Reactive oxygen species and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes","volume":"114","author":"Kavoosi","year":"2006","journal-title":"Exp Parasitol"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3275662","article-title":"Some aspects of immunity to intracellular protozoan parasites","volume":"49","author":"Stauber","year":"1963","journal-title":"J Parasitol"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"e108556","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: Comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14411\/fp.2013.001","article-title":"Evaluation of anti-leishmanial effects of killed Leishmania vaccine with BCG adjuvant in BALB\/c mice infected with Leishmania major MRHO\/IR\/75\/ER","volume":"60","author":"Nahrevanian","year":"2013","journal-title":"Folia Parasitol (Praha)"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1369-5274(02)00286-2","article-title":"A phagosome of one\u2019s own: A microbial guide to life in the macrophage","volume":"5","author":"Amer","year":"2002","journal-title":"Curr Opin Microbiol"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major","volume":"24","author":"Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"R27-20260506","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"key":"R28-20260506","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania vaccines: The current situation with its promising aspect for the future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J Parasitol"},{"key":"R29-20260506","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/320994","article-title":"Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: Implications for the mechanism underlying drug cure","volume":"184","author":"Hailu","year":"2001","journal-title":"J Infect Dis"},{"key":"R30-20260506","doi-asserted-by":"crossref","first-page":"e.773983","DOI":"10.3389\/fimmu.2021.773983","article-title":"Multifunctional, TNF-\u03b1 and IFN-\u03b3-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis","volume":"12","author":"Rodrigues","year":"2021","journal-title":"Front Immunol"},{"key":"R31-20260506","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","article-title":"Potential biomarkers of immune protection in human leishmaniasis","volume":"210","author":"Rostami","year":"2021","journal-title":"Med Microbiol Immunol"},{"key":"R32-20260506","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell Immunol"},{"key":"R33-20260506","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"R34-20260506","doi-asserted-by":"crossref","first-page":"e3908061","DOI":"10.1155\/2017\/3908061","article-title":"The role of IL 17 and related cytokines in inflammatory autoimmune diseases","volume":"2017","author":"Kuwabara","year":"2017","journal-title":"Mediators Inflamm"}],"container-title":["Tropical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tp.tp_10_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:42:51Z","timestamp":1786650171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tp.tp_10_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tp.tp_10_25","relation":{},"ISSN":["2229-5070","2229-7758"],"issn-type":[{"value":"2229-5070","type":"print"},{"value":"2229-7758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-01-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}